TXG 10x Genomics, Inc.

TSX

$85.71

10x Genomics, Inc. (TXG) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $0.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +88.3% since its last earnings release on August 6, 2026.

10x Genomics Beat Consensus Estimates, Raises Guidance, but Remains In-line with Estimates

Thursday, August 6, 2026 · 4:02 PM ET

Earnings Date

3rd Quarter, Sep 2026

Nov 4

Wednesday · 4:00 PM ET

Earnings Whisper

vs ($0.27)

Rev est $147.47M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis